Fibromat (M) Berhad (KLSE:FIBRO)
Malaysia · Delayed Price · Currency is MYR 0.8000
+0.0100 (1.27%)
At close: Aug 28, 2026
Fibromat (M) Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 135.21 | 113.48 | 75.46 | 68.3 | 47.95 | 45.79 | |
Revenue Growth | 55.87% | 50.38% | 10.49% | 42.43% | 4.73% | 3.42% |
Cost of Revenue | 97.83 | 79.63 | 54.76 | 51.16 | 37.42 | 33.99 |
Gross Profit | 37.38 | 33.85 | 20.71 | 17.14 | 10.54 | 11.8 |
Selling, General & Admin | 9.86 | 9.9 | 6.28 | 5.2 | 5.01 | 4.02 |
Other Operating Expenses | -0.36 | -0.26 | 0.35 | 0.07 | -0.63 | -0.5 |
Operating Expenses | 9.5 | 9.64 | 6.63 | 5.27 | 4.38 | 3.52 |
Operating Income | 27.88 | 24.21 | 14.07 | 11.86 | 6.15 | 8.28 |
Interest Expense | -1.5 | -0.77 | -1.02 | -1.01 | -0.92 | -0.47 |
Interest & Investment Income | 0.14 | 0.14 | 0.03 | 0.03 | 0.03 | 0.03 |
Currency Exchange Gain (Loss) | - | - | 0.24 | 0.13 | 0.1 | 0.04 |
Other Non Operating Income (Expenses) | -0.97 | -0.97 | -0.04 | -0.04 | -0.03 | -0.07 |
EBT Excluding Unusual Items | 25.55 | 22.61 | 13.28 | 10.98 | 5.32 | 7.81 |
Gain (Loss) on Sale of Assets | - | - | 0.01 | 0.25 | 0.11 | - |
Pretax Income | 25.56 | 22.61 | 13.43 | 11.23 | 5.43 | 7.85 |
Income Tax Expense | 6.94 | 6.23 | 3.46 | 2.74 | 1.9 | 2.1 |
Net Income | 18.62 | 16.39 | 9.97 | 8.49 | 3.54 | 5.75 |
Net Income to Common | 18.62 | 16.39 | 9.97 | 8.49 | 3.54 | 5.75 |
Net Income Growth | 53.42% | 64.31% | 17.47% | 140.07% | -38.53% | -29.35% |
Shares Outstanding (Basic) | 248 | 237 | 216 | 216 | 216 | 216 |
Shares Outstanding (Diluted) | 248 | 237 | 216 | 216 | 216 | 216 |
Shares Change | 12.47% | 9.83% | - | - | - | - |
EPS (Basic) | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.03 |
EPS (Diluted) | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.03 |
EPS Growth | 36.41% | 49.62% | 17.47% | 140.07% | -38.53% | -29.35% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -23.94 | -26.93 | 2.91 | 12.41 | -1.46 | 2.61 |
Free Cash Flow Per Share | -0.10 | -0.11 | 0.01 | 0.06 | -0.01 | 0.01 |
Dividend Per Share | - | - | 0.010 | 0.010 | 0.014 | 0.023 |
Dividend Growth | - | - | 0% | -28.57% | -39.13% | 64.29% |
Gross Margin | 27.64% | 29.83% | 27.44% | 25.09% | 21.97% | 25.77% |
Operating Margin | 20.62% | 21.33% | 18.65% | 17.37% | 12.83% | 18.08% |
Profit Margin | 13.77% | 14.44% | 13.22% | 12.43% | 7.38% | 12.57% |
Free Cash Flow Margin | -17.71% | -23.73% | 3.86% | 18.17% | -3.04% | 5.70% |
EBITDA | 32.25 | 27.28 | 15.89 | 13.54 | 7.49 | 9.48 |
EBITDA Margin | 23.85% | 24.04% | 21.05% | 19.83% | 15.61% | 20.70% |
D&A For EBITDA | 4.37 | 3.07 | 1.81 | 1.68 | 1.33 | 1.2 |
EBIT | 27.88 | 24.21 | 14.07 | 11.86 | 6.15 | 8.28 |
EBIT Margin | 20.62% | 21.33% | 18.65% | 17.37% | 12.83% | 18.08% |
Effective Tax Rate | 27.14% | 27.53% | 25.74% | 24.39% | 34.91% | 26.70% |